Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
APTX.TO
HoldFallen FavouriteApotex Health Corp. · Healthcare · Canada · $5.4B · Avg Vol: $8M/d
46
StockRankGet insider-trade alerts
Q
61
V
40
M
37
P/E (TTM)
—
ROE
—
D/E
8.6x
Dividend %
—
Loading 1Y...
PRICE (1Y)-6.4%
SMA 50SMA 200
Close
$24.30
RSI (14)
41.6
SCORE BREAKDOWN
Quality
61
ROIC
24.6%94.8
ROE
—N/A
GP/Assets
35.7%73.2
Op. Margin
11.4%69.1
FCF/Assets
10.1%87.2
Piotroski
377.2
Int. Cover
3.1x48.8
D/E Ratio
8.63x1.3
Current Ratio
1.77x33.2
Value
40
P/E (TTM)
—N/A
EV/EBITDA
13.7x50.6
P/FCF
16.1x66.2
P/B
21.9x5.1
P/S
2.4x62.4
Div Yield
—N/A
Momentum
37
52W High %
—N/A
RS 6M
—N/A
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+2069%99.2
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$5.4B
P/E (Forward)
14.2x
Gross Margin
50.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of APTX.TO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| APTX.TO | Apotex Health Corp.(you) | $5.4B | 46 | Hold |
| CRON | Cronos Group Inc. | $1.2B | 68 | Buy |
| BHC.TO | Bausch Health Companies Inc. | $2.5B | 86 | Strong Buy |
| ACB.TO | Aurora Cannabis Inc. | $253M | 40 | Hold |
| WEED.TO | Canopy Growth Corporation | $461M | 24 | Sell |
| GUD.TO | Knight Therapeutics Inc. | $682M | 76 | Buy |
| TSND.TO | TerrAscend Corp. | $243M | 60 | Hold |
| TLRY | Tilray Brands, Inc. | $631M | 13 | Strong Sell |
| CRDL.TO | Cardiol Therapeutics Inc. | $252M | 23 | Sell |
| OGI | Organigram Global Inc. | $171M | 63 | Hold |
Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 44.2%